
Advertise on podcast: AUAUniversity
Rating
4.4from
This podcast has
428 episodes
Language
EnglishPublisher
American Urological AssociationExplicit
No
Date created
2016/04/08
Latest episode
2026/11/18
Average duration
42 min.
Release period
7 days
Description
The AUAUniversity podcast is an official podcast of the American Urological Association. More information can be found at https://auau.auanet.org
Unlock AUAUniversity podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from AUAUniversity podcast
Kidney & Ureteral Stones: What’s New in Surgical Management & Guidelines
2026/11/18
Kidney & Ureteral Stones: What’s New in Surgical Management & Guidelines
CME Available: cme.auanet.org/URL/STONES26POD
LEARNING OBJECTIVES:
After participating in this activity, participants will be able to:
1. Align practice patterns with the newly released AUA Surgical Management of Kidney and Ureteral Stones Clinical Guideline.
2. Identify what is new and what remains unchanged in the newly released AUA Surgical Management of Kidney and Ureteral Stones Clinical Guideline.
3. Evaluate current and new technologies, including pivotal studies, and determine the role and clinical expectation for each of them.
4. Interpret the current clinical results and compare the patient experiences of the new treatment alternatives for treating kidney and ureteral stones in relation to more established treatments for patient groups with similar characteristics.
5. Manage complex medical scenarios with kidney stones, including more complex clinical scenarios that are not specifically addressed in the current AUA Guideline
6. Apply techniques to mitigate the complications and risks that can occur during stone management.
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
- Coloplast
- Olympus Corporation of the Americas
© 2026 AMERICAN UROLOGICAL ASSOCIATION. ALL RIGHTS RESERVED.
ATTENTION: You are prohibited from using or uploading content you accessed through this activity into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
NMIBC Guideline Update for Urologists: What's Changed and Why it Matters
2026/11/11
NMIBC Guideline Update for Urologists: What's Changed and Why it Matters
CME Available: https://cme.auanet.org/URL/NMIBCURO261ONL
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Evaluate emerging clinical trial data and updates to AUA/SUO NMIBC guidelines in the context of high recurrence and complication rates in order to incorporate evidence- based adjustments into current treatment paradigms.
2. Apply guideline-directed risk stratification tools to identify and select appropriate patients with high-risk NMIBC, in order to personalize therapy selection and sequencing.
3. Integrate best practices for the safe and effective use of novel intravesical and systemic immunotherapies into NMIBC care pathways, with an emphasis on collaboration between urology and medical oncology to optimize shared decision-making.
4. Implement patient-centered strategies to reduce disease recurrence and mitigate treatment-related adverse events.
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
- AstraZeneca
- Immunity Bio, Inc
- Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
- Urogen, Inc.
Update Series (2026): Antibiotic Stewardship in Office Urology—A Case-Based Approach
2026/11/04
Update Series (2026): Antibiotic Stewardship in Office Urology—A Case-Based Approach
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: E. Ann Gormley, MD, MSc
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
For more information or to subscribe to the AUA Update Series, please visit CME.auanet.org
Emerging Technology Spotlight: AI-Enabled Remote Uroflowmetry
2026/10/28
Emerging Technology Spotlight: AI-Enabled Remote Uroflowmetry
Subscribe to the AUA Leadership & Business Podcast today by clicking on one of the links below or searching "Leadership and Business" on your favorite podcast app!
Apple Podcast: https://podcasts.apple.com/us/podcast/aua-leadership-and-business/id1646701227
YouTube Music: https://music.youtube.com/playlist?list=PLmlqgyiBVx1HGqaUsLmAErH472CyzBlLF
Spotify: https://open.spotify.com/show/3jZthzjFAHwRSsV72D4JlL
Advances in Prostate Stents
2026/10/21
Advances in Prostate Stents
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Ricardo R. Gonzalez, MD
AUA Guidelines: Medical & Surgical Management of Kidney and Ureteral Stones
2026/10/14
AUA Guidelines: Medical & Surgical Management of Kidney and Ureteral Stones
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Kevin Koo, MD, MPH, MPhil
To access the full Medical Management of Kidney Stones guideline, please use the following link: https://www.auanet.org/guidelines-and-quality/guidelines/medical-management-of-kidney-stones
To access the full Surgical Management of Kidney and Ureteral Stones guideline, please use the following link: https://www.auanet.org/guidelines-and-quality/guidelines/surgical-management-of-kidney-and-ureteral-stones
Update Series (2026) Lesson 27: Case-Based Discussion of the Male Chronic Pelvic Pain Guideline
2026/10/07
Update Series (2026) Lesson 27: Case-Based Discussion of the Male Chronic Pelvic Pain Guideline
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
For more information or to subscribe to the AUA Update Series, please visit cme.auanet.org/URL/US2026
Core Curriculum: Pediatric Oncology
2026/09/30
Core Curriculum: Pediatric Oncology
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Amanda F. Buchanan, MD
AUA Urology Core Curriculum: https://cme.auanet.org/Page/Core-Curriculum
Outline:
Segment 1: Renal Masses in Children 12y
Segment 3: Testicular GCT
Segment 4: Bladder/Prostate RMS
Segment 5: Paratestis RMS
Starting HoLEP without Fellowship Training
2026/09/23
Starting HoLEP without Fellowship Training
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Daniel S. Kellner, MD
AUA Guidelines: Vasectomy
2026/09/16
AUA Guidelines: Vasectomy
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Richard Lee, MD, MBA
To access the full guideline, please use the following link: https://www.auanet.org/guidelines-and-quality/guidelines/vasectomy-guideline
Microultrasound for the Detection of Prostate Cancer
2026/09/09
Microultrasound for the Detection of Prostate Cancer
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Christian P. Pavlovich, MD
AUA Guidelines: Non-Muscle Invasive Bladder Cancer
2026/09/03
AUA Guidelines: Non-Muscle Invasive Bladder Cancer
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: Peter E. Clark, MD and Jeffrey M. Holzbeierlein, MD, FACS
To access the full guideline, please use the following link: https://www.auanet.org/guidelines-and-quality/guidelines/bladder-cancer-non-muscle-invasive-guideline
Please note that access to the full guideline requires user login. If you do not already have an account, you can create a free login.
Update Series (2026): Evaluating Abnormal Urine Cytology Without Clinically Demonstrable Urinary Tract Disease
2026/09/02
Update Series (2026): Evaluating Abnormal Urine Cytology Without Clinically Demonstrable Urinary Tract Disease
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Sherri M. Donat, MD
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
For more information or to subscribe to the AUA Update Series, please visit CME.auanet.org
AUA2026: Advanced Prostate Cancer in the News 2026: A Case-Based Multidisciplinary Update
2026/08/24
AUA2026: Advanced Prostate Cancer in the News 2026: A Case-Based Multidisciplinary Update
CME Available: https://cme.auanet.org/URL/26DC010ONL
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Initial Management of Metastatic Prostate Cancer: Evaluate and treat a patient with new diagnosed M1 prostate cancer with androgen deprivation therapy (ADT) plus be skilled to offer novel oral androgen blockers/inhibitors. Furthermore, to recognize high volume new M1 prostate cancer so as to be able to partner with GU medical oncologist for docetaxel chemotherapy in a multidisciplinary team. In addition, to recognize and employ molecular genetic testing to help dictate proper therapy.
2. Non Metastatic Castrate Resistant Prostate Cancer (M0 CRPC): Diagnose M0CRPC and to be able to educate patients about using novel oral androgen receptor targeted agents added to traditional ADT as a way to improve their patent's overall and radiographic progression-free survival. Furthermore, the skilled learner will be able to understand the differences between these three novel oral agents and to educate patients about side-effects and toxicities. Finally, to understand the pros and cons of PSMA PET scan imaging in further staging in this disease state.
3. Metastatic Castrate Resistant Prostate Cancer (M1 CRPC): Define and have a working knowledge of the latest phase III RCT results for new therapies in M1 CRPC and to be able to educate their patients on treatment options and be able to participate in a multidisciplinary team caring for men with this disease state of far advanced prostate cancer.
4. Identify that advanced prostate cancer is a complex group of disease states with an ever changing therapeutic landscape and for providers and teams to embrace the multi-disciplinary nature of care for our patients.
5. Describe the molecular and molecular genetic underpinnings of advanced prostate cancer and recognize the future will be based on a more personalized therapy landscape including PARP inhibition, Immune Checkpoint agents and novel AR targeted agents emerging in 2026 and beyond.
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
Astellas
Lantheus Medical Imaging
Novartis Pharmaceuticals Corporation
Pfizer, Inc
AUA2026: Should I Order a PET Scan? Integrating Molecular Imaging into Urologic Oncology
2026/08/21
AUA2026: Should I Order a PET Scan? Integrating Molecular Imaging into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities
CME Available: https://cme.auanet.org/URL/26DC041ONL
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Analyze the best available evidence on the current diagnostic imaging options for prostate, kidney, bladder, and testis cancer detection, staging, and follow-up.
2. Describe the benefits of combined functional and anatomic information gained through accurate matching of anatomic (CT/MRI) and functional (PET) images.
3. Debate the strengths and limitations of emerging molecular imaging techniques compared to existing diagnostic tests.
4. Optimally stage urologic oncology patients by understanding the performance characteristics of standard and emerging molecular imaging modalities.
5. Define the emerging role of PET imaging and novel radiotracers to assess chemotherapy and immunotherapy response.
6. Formulate a strategic plan for appropriate integration of molecular imaging into clinical practice.
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
Astellas
Lantheus Medical Imaging
Novartis Pharmaceuticals Corporation
Pfizer, Inc
Podcast reviews
Read AUAUniversity podcast reviews
RobynMomDoc4 2026/06/30
good content
Shorten it up- more bullet points and less verbiage.
Brooke Sundy 2024/07/28
Be better
Great content, but some of the audio quality is so bad it’s intolerable to listen to
uro_anonymoius 2021/08/09
Very good content, music is not nice
Please get rid of music in beginning and end. It’s difficult to hear the speakers over it. Also some audio quality is not good.
Content is excellent ...
JJHam 2021/01/20
Very good content, but please fix the audio component so that I can actually hear the podcast
Excellent series on GU malignancies at the end of 2020. Please please please fix the audio to make it legible.
FidoPDP 2018/03/15
Thank you
Perfect for my long drives to a satellite hospital.
Podcast sponsorship advertising
Start advertising on AUAUniversity relevant audience podcasts
You may also like to advertise on these Podcasts

4.861551136
The David Pakman Show
David Pakman

4.6254042000
The Glenn Beck Program
Mercury Radio Arts

4.6652752197
The Charlie Kirk Show
Charlie Kirk

4.736091328
The Bonfire with Big Jay Oakerson and Robert Kelly
SiriusXM

4.732782000
The President's Daily Brief
The First TV

4.922782003
First15 Devotional
First15

4.853622000
Men In Blazers
Men In Blazers

4.897071460
The Graham Allen Show
Graham Allen

4.82494978
The 1000 Hours Outside Podcast
1000 Hours Outside

4.715161997
Thrivetime Show | Business School without the BS
Clay Clark